HEALTH● LOWAug 19 · Aug 19, 2026, 2:56 PM
Merck, Moderna claim encouraging melanoma vaccine trial results
South China Morning Post
US pharmaceutical firms Merck and Moderna announced on Wednesday encouraging results from a trial of their experimental vaccine against melanoma, potentially clearing the way for approval. The vaccine, called intismeran autogene, showed “statistically significant and clinically meaningful improvements” for skin cancer patients when used with Merck’s Keytruda treatment, the companies said in a statement. Unlike conventional vaccines, so-called therapeutic vaccines like intismeran treat rather...
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH47m agoCaffeine pouches are trapping children in a 'vicious cycle' - and their use can be hard to detectThe Independent WorldHEALTH1h agoKarnataka to set up committee to boost deceased donor organ transplantsThe HinduHEALTH1h agoKarnataka to frame policy against hospitals withholding bodies over unpaid billsThe HinduHEALTH1h agoUnitedHealthcare, Humana Medicare Advantage cancellations to affect 1 millionThe Hill